Filtered By:
Cancer: Liver Cancer

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 34443 results found since Jan 2013.

Extra-vascular findings in patients undergoing magnetic resonance angiography of the abdomen, pelvis and lower extremities: A retrospective study of 352 patients.
Conclusions Extravascular findings are frequently encountered in magnetic resonance angiography performed for vascular indications. Clinically relevant findings are seen in a substantial part of patients and should prompt further diagnostic work-up. PMID: 28587578 [PubMed - as supplied by publisher]
Source: Vascular - January 1, 2017 Category: Surgery Authors: Sohns JM, Menke J, Bergau L, Weiss BG, Schmuck S, Weiberg D, Staab W, Derlin T, Dorenkamp M, Sohns C Tags: Vascular Source Type: research

Metastatic breast carcinoma induces vascular endothelial dysfunction in Balb-c mice: Role of the tumor necrosis factor-α and NADPH oxidase.
In this study, highly metastatic breast carcinoma cells which was derived from liver or brain metastasis of 4T1 murine breast carcinoma (4TLM and 4TBM, respectively), and 67NR cells which is tumorogenic but non-metastatic cells were used. Female Balb-c mice 8-10weeks old were divided into following groups: (1) Control, (2) injected with 67NR, (3) injected with 4TLM, and (4) injected with 4TBM orthotopically. Thoracic aorta was removed 23-25days after injection of tumor cells. Isometric tension studies were performed in response to potassium chloride (KCl), phenylephrine (Phe), acetylcholine (ACh, an endothelium-dependent v...
Source: Vascular Pharmacology - August 7, 2013 Category: Drugs & Pharmacology Authors: Dalaklioglu S, Tasatargil A, Kale S, Gamzetanriover, Dilmac S, Erin N Tags: Vascul Pharmacol Source Type: research

Hepatic Extracellular Signal-Regulated Kinase 2 Suppresses Endoplasmic Reticulum Stress and Protects From Oxidative Stress and Endothelial Dysfunction Vascular Medicine
Conclusions Hepatic ERK2 suppresses endoplasmic reticulum stress and hepatosteatosis in vivo, which results in protection from vascular oxidative stress and endothelial dysfunction. These findings demonstrate a novel role of hepatic ERK2 in obese-induced insulin resistance in the protection from hepatovascular metabolic remodeling and vascular diseases.
Source: JAHA:Journal of the American Heart Association - August 16, 2013 Category: Cardiology Authors: Kujiraoka, T., Satoh, Y., Ayaori, M., Shiraishi, Y., Arai-Nakaya, Y., Hakuno, D., Yada, H., Kuwada, N., Endo, S., Isoda, K., Adachi, T. Tags: Vascular Medicine Source Type: research

Quantification of Blood Pressure Changes in the Vascular Compartment When Using an Anti-Reflux Catheter during Chemoembolization versus Radioembolization: A Retrospective Case Series
Conclusions Hepatic arterial pressures in the treated vascular compartment increased more after transarterial chemoembolization than after TARE, suggesting that transarterial chemoembolization resulted in more embolic obstruction of the targeted vascular compartment than TARE.
Source: Journal of Vascular and Interventional Radiology - November 10, 2016 Category: Radiology Source Type: research

A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial–mesenchymal transition–independent manner
Conclusion: Our findings identify a novel metastasis mechanism that relies on vascular pattern but is independent of EMT, which may provide new targets for antimetastasis therapy and offer a basis for selecting patients who may benefit from certain molecularly targeted drugs. (Hepatology 2015)
Source: Hepatology - April 22, 2015 Category: Internal Medicine Authors: Jian‐Hong Fang, Hui‐Chao Zhou, Chong Zhang, Li‐Ru Shang, Lei Zhang, Jing Xu, Limin Zheng, Yunfei Yuan, Rong‐Ping Guo, Wei‐Hua Jia, Jing‐Ping Yun, Min‐Shan Chen, Yaojun Zhang, Shi‐Mei Zhuang Tags: A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an EMT‐independent manner Source Type: research

Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association
Arterioscler Thromb Vasc Biol. 2022 Apr 14:101161ATV0000000000000153. doi: 10.1161/ATV.0000000000000153. Online ahead of print.ABSTRACTNonalcoholic fatty liver disease (NAFLD) is an increasingly common condition that is believed to affect >25% of adults worldwide. Unless specific testing is done to identify NAFLD, the condition is typically silent until advanced and potentially irreversible liver impairment occurs. For this reason, the majority of patients with NAFLD are unaware of having this serious condition. Hepatic complications from NAFLD include nonalcoholic steatohepatitis, hepatic cirrhosis, and hepatocellular ...
Source: Arteriosclerosis, Thrombosis and Vascular Biology - April 14, 2022 Category: Cardiology Authors: P Barton Duell Francine K Welty Michael Miller Alan Chait Gmerice Hammond Zahid Ahmad David E Cohen Jay D Horton Gregg S Pressman Peter P Toth American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Hypertension Source Type: research

Sorafenib Alone versus Sorafenib Combined with Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses Vascular and Interventional Radiology
Conclusion: In this retrospective study, TACE plus sorafenib was superior to sorafenib alone with respect to TTP in patients with advanced-stage HCC, although it may or may not improve OS. © RSNA, 2013 Supplemental material: http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.13130150/-/DC1
Source: Radiology - October 23, 2013 Category: Radiology Authors: Choi, G. H., Shim, J. H., Kim, M.-J., Ryu, M.-H., Ryoo, B.-Y., Kang, Y.-K., Shin, Y. M., Kim, K. M., Lim, Y.-S., Lee, H. C. Tags: Vascular Imaging Vascular and Interventional Radiology Source Type: research

Chemoembolization with Vascular Disrupting Agent CKD-516 Dissolved in Ethiodized Oil in Combination with Doxorubicin: A  VX2 Tumor Model Study
Conclusions Treatment with a combination of CKD-516 and conventional transarterial chemoembolization showed therapeutic benefit in a liver tumor model.
Source: Journal of Vascular and Interventional Radiology - June 16, 2018 Category: Radiology Source Type: research

Chemoembolization with Vascular Disrupting Agent CKD-516 Dissolved in Ethiodized Oil in Combination with Doxorubicin: A VX2 Tumor Model Study
ConclusionsTreatment with a combination of CKD-516 and conventional transarterial chemoembolization showed therapeutic benefit in a liver tumor model.
Source: Journal of Vascular and Interventional Radiology - July 5, 2018 Category: Radiology Source Type: research